Dextroverse >> Links to Main Site & User Controls

Dextroverse IRC Chat!
Server: irc.dextroverse.org
Ports: 6667 or 7000 SSL: 6697 or 9999
Room: #dextroverse

DV IRC How-To || mIRC Chat Link
Dextroverse Donations!
$65.00$100.00
Our goal is $100.00 in monthly donations to pay for the server costs
We currently have $65.00 per month.
Donate $5.00/month via PayPal || Full Donation Information || Make a One-Time Donation
SITE NEWS: Incriminating Pictures & Your Safety
Be a part of the Dextroverse DXM Community!
Registration is free and only takes a moment!
Choose a Username and Password, Login, Write a Short 200-Word Introduction, and Join the Community!

- Gain Access to 15+ Member Only Forums!
- Be able to Reply and Post New Topics!
- Comment on Latest DXM News!
- Access to a Private Messenger!
- Access to your own Control Panel!
- Be able to create your own Profile!
- Set your own options of how to view the forums!
- Use Many More Member Features!
( Log In | Register )



Help | Search | Members | Calendar
 
Cough medicine fights dyskinesias in Parkinson's, PORTLAND, OR
« Next Oldest | Next Newest » Track this topic | Email this topic | Print this topic
drdªv€
Posted: Nov 7 2007, 12:02 PM


Santa called me a HO... 3 times!


Group: Lead Administrators
Posts: 2877
Member No.: 140
Joined: 17-June 03




PORTLAND, Ore. - A cough suppressant and a drug tested as a schizophrenia therapy curb the involuntary movements that are disabling side effects of taking the Parkinson's disease medication levodopa, Portland scientists have found.

Dextromethorphan, used in such cold and flu medications as Robitussin, Sucrets, Triaminic and Vicks, suppresses dyskinesias in rats, researchers at Oregon Health & Science University and the Portland Veterans Affairs Medical Center found. Dyskinesias are the spastic or repetitive motions that result from taking levodopa, or L-dopa, over long periods.

The researchers also found that BMY-14802, a drug previously tested in people with schizophrenia and found to be safe – although not effective in treating schizophrenia symptoms – suppressed dyskinesias in rats more effectively than dextromethorphan did, suggesting that BMY-14802 might work to block dyskinesias in people with Parkinson's.

"These results were unexpected, but very exciting," said the study's lead author, Melanie A. Paquette, Ph.D., postdoctoral fellow in the Department of Behavioral Neuroscience, OHSU School of Medicine, and the PVAMC. "We have filed a patent for the use of BMY-14802 for dyskinesias and we hope to get funding to begin human trials very soon."

The study, titled "Differential effects of NMDA antagonists and sigma ligands on L-dopa-induced behavior in the hemiparkinson rat," is being presented during a poster session today at Neuroscience 2007, the 37th annual Society for Neuroscience conference in San Diego.

The results also affirm the value of the rat model for dyskinesias that Paquette's team used in the study. Previous studies by other researchers have shown the drug amantadine already is effective in treating dyskinesias in both humans and rats, and dextromethorphan's effectiveness against the condition in rats provides more data supporting the use of the model.

"Basically, these two drugs work to block dyskinesias in both humans and rats, and that means the rats are a good model to screen potential drug treatments for humans with dyskinesias," Paquette said.

But BMY-14802, which is an antagonist at sigma-1 receptor sites in the brain, "worked much better than dextromethorphan," an antagonist at N-methyl-D-aspartate (NMDA) receptors.

"There's something special about BMY-14802," Paquette explained. "The effect on dyskinesias is really striking and I've repeated it several times, so it's a reliable finding. It's a very exciting result."


###
The study was funded by the National Institute on Drug Abuse and the National Institute of Neurological Disorders and Stroke, National Institutes of Health, and the U.S. Department of Veterans Affairs.

http://www.eurekalert.org/pub_releases/200...s-cmf110707.php

--------------------
Growing old is mandatory... growing up is optional. ;)

Know your body, Known your mind, Know your substance, Know your source

RIP RDT 12-27-65/6-04-06
Brother, Friend, Confidante & Co-Conspirator


"All of my heroes have now become ghosts"

"friends help you move... best friends help you move bodies."

back to top 
        top
libel
Posted: Nov 7 2007, 02:10 PM


Tree Hugger


Group: IRC Operators
Posts: 4160
Member No.: 51
Joined: 11-June 03




Glad to see this chemical find additional medicinal use.


back to top 
      top
DEXmonic
Posted: Nov 7 2007, 05:41 PM


Dextroverse Regular


Group: Members
Posts: 760
Member No.: 9299
Joined: 13-February 07




Does that mean we might see some pure DXM floating around again? No more chugging syrup? Also, does anyone know if BMY-14802 acts in the same way as DXM - except stronger?

Anyways, I am also glad to see they are finding other uses for this.

--------------------

back to top 
       top
2 replies since Nov 7 2007, 12:02 PM Track this topic | Email this topic | Print this topic

<< Back to DXM-related News

 





© 2000-2007 Dextroverse Inc.

Site developed by Void

Site redesign by Væ§ølis

Forum Skin & Designs by PeoplesMind